X-ray Dose Reduction Study for Endovascular Interventional Radiology

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Cardiovascular Disease
Interventions
RADIATION

Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.

Digital Subtraction Angiography (DSA) of iliac artery with reduced dose settings (83% dose reduction expected) in combination with novel X-ray imaging technology.

RADIATION

Normal dose DSA with conventional X-ray imaging technology

Digital Subtraction Angiography (DSA) of iliac artery with normal dose settings in combination with conventional X-ray imaging technology.

Trial Locations (1)

3430 EM

St. Antonius Ziekenhuis, Nieuwegein

All Listed Sponsors
lead

Philips Clinical & Medical Affairs Global

INDUSTRY

NCT01599741 - X-ray Dose Reduction Study for Endovascular Interventional Radiology | Biotech Hunter | Biotech Hunter